Literature DB >> 24153013

Altered expression of miR-24, miR-126 and miR-365 does not affect viability of childhood TCF3-rearranged leukemia cells.

F Akbari Moqadam1, J M Boer1, E A M Lange-Turenhout1, R Pieters1, M L den Boer1.   

Abstract

Among the microRNAs (miRNAs) that control different cellular processes, miR-24, miR-126 and miR-365 were shown to regulate cell cycle progression and apoptosis in various types of tumors. Interestingly, these three miRNAs were downregulated in pediatric TCF3-rearranged B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Here, we showed that individual or combined overexpression of miR-24, miR-126 and miR-365 can neither alter the cell cycle progression nor the amount of apoptosis in 697, KASUMI-2 or MHH-CALL-3 TCF3-rearranged leukemic cells. We further integrated the miRNA-mRNA expression data of 37 children with BCP-ALL to identify candidate target genes for these three miRNAs. However, the expression levels of selected candidate target genes (ELL, EBF3 and IRF4 for miR-24, PITPNC1 for miR-126 and ZAP-70 for miR-365) did not reduce upon miRNAs overexpression in MHH-CALL-3 TCF3-rearranged leukemic cells. Although the expression level of AURKB-a validated target for miR-24-was reduced upon miR-24 overexpression in hepatocarcinoma HEP-G2 cells, overexpression of miR-24 cannot alter AURKB expression levels in MHH-CALL-3 TCF3-rearranged leukemic cells. Taken together, our data suggest that miRNAs' function is highly tissue-dependent and that a defined biological target gene or function of one miRNA in a specific tissue cannot be extended as a generalized target/function for that miRNA in all types of cells/tissues.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24153013     DOI: 10.1038/leu.2013.308

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  47 in total

1.  Regulation of heme oxygenase-1 protein expression by miR-377 in combination with miR-217.

Authors:  Joan D Beckman; Chunseng Chen; Julia Nguyen; Venugopal Thayanithy; Subbaya Subramanian; Clifford J Steer; Gregory M Vercellotti
Journal:  J Biol Chem       Date:  2010-11-24       Impact factor: 5.157

2.  miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5.

Authors:  Edit Miko; Zoltán Margitai; Zsolt Czimmerer; Ildikó Várkonyi; Balázs Dezso; Arpád Lányi; Zsolt Bacsó; Beáta Scholtz
Journal:  FEBS Lett       Date:  2011-03-23       Impact factor: 4.124

3.  GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia.

Authors:  T Holmlund; M J Lindberg; D Grander; A E Wallberg
Journal:  Leukemia       Date:  2012-09-11       Impact factor: 11.528

Review 4.  MicroRNA and cancer.

Authors:  Martin D Jansson; Anders H Lund
Journal:  Mol Oncol       Date:  2012-10-09       Impact factor: 6.603

5.  MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia.

Authors:  F Akbari Moqadam; E A M Lange-Turenhout; I M Ariës; R Pieters; M L den Boer
Journal:  Leuk Res       Date:  2013-07-31       Impact factor: 3.156

6.  miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein.

Authors:  Yan Guo; Weineng Fu; Hong Chen; Chao Shang; Ming Zhong
Journal:  Oncol Rep       Date:  2011-11-30       Impact factor: 3.906

7.  IRF4 is a suppressor of c-Myc induced B cell leukemia.

Authors:  Simanta Pathak; Shibin Ma; Long Trinh; James Eudy; Kay-Uwe Wagner; Shantaram S Joshi; Runqing Lu
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

8.  Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia.

Authors:  Dan-Dan Feng; Hua Zhang; Peng Zhang; Yu-Sheng Zheng; Xing-Ju Zhang; Bo-Wei Han; Xue-Qun Luo; Ling Xu; Hui Zhou; Liang-Hu Qu; Yue-Qin Chen
Journal:  J Cell Mol Med       Date:  2011-10       Impact factor: 5.310

9.  miRecords: an integrated resource for microRNA-target interactions.

Authors:  Feifei Xiao; Zhixiang Zuo; Guoshuai Cai; Shuli Kang; Xiaolian Gao; Tongbin Li
Journal:  Nucleic Acids Res       Date:  2008-11-07       Impact factor: 16.971

10.  Integrated analysis of microRNA and mRNA expression: adding biological significance to microRNA target predictions.

Authors:  Maarten van Iterson; Sander Bervoets; Emile J de Meijer; Henk P Buermans; Peter A C 't Hoen; Renée X Menezes; Judith M Boer
Journal:  Nucleic Acids Res       Date:  2013-06-14       Impact factor: 16.971

View more
  15 in total

1.  Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.

Authors:  Karolina Nemes; Monika Csóka; Noémi Nagy; Ágnes Márk; Zsófia Váradi; Titanilla Dankó; Gábor Kovács; László Kopper; Anna Sebestyén
Journal:  Pathol Oncol Res       Date:  2014-11-12       Impact factor: 3.201

2.  Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes.

Authors:  Chihiro Tomoyasu; Toshihiko Imamura; Toshihiro Tomii; Mio Yano; Daisuke Asai; Hiroaki Goto; Akira Shimada; Masashi Sanada; Shotaro Iwamoto; Junko Takita; Masayoshi Minegishi; Takeshi Inukai; Kanji Sugita; Hajime Hosoi
Journal:  Int J Hematol       Date:  2018-05-21       Impact factor: 2.490

3.  Increased expression of miR-24 is associated with acute myeloid leukemia with t(8;21).

Authors:  Jia-Yu Yin; Qin Tang; Wei Qian; Jun Qian; Jiang Lin; Xiang-Mei Wen; Jing-Dong Zhou; Ying-Ying Zhang; Xiao-Wen Zhu; Zhao-Qun Deng
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 4.  Versatile role of miR-24/24-1*/24-2* expression in cancer and other human diseases.

Authors:  Sanjukta Mukherjee; Bhagyashree Shelar; Sudhir Krishna
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

Review 5.  MicroRNAs, genomic instability and cancer.

Authors:  Kimberly Vincent; Martin Pichler; Gyeong-Won Lee; Hui Ling
Journal:  Int J Mol Sci       Date:  2014-08-20       Impact factor: 5.923

6.  Identification and analysis of differentially expressed long non-coding RNAs between multiparous and uniparous goat (Capra hircus) ovaries.

Authors:  Yinghui Ling; Lina Xu; Long Zhu; Menghua Sui; Qi Zheng; Wenyong Li; Yong Liu; Fugui Fang; Xiaorong Zhang
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

7.  Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines.

Authors:  Kazuya Takahashi; Takeshi Inukai; Toshihiko Imamura; Mio Yano; Chihiro Tomoyasu; David M Lucas; Atsushi Nemoto; Hiroki Sato; Meixian Huang; Masako Abe; Keiko Kagami; Tamao Shinohara; Atsushi Watanabe; Shinpei Somazu; Hiroko Oshiro; Koshi Akahane; Kumiko Goi; Jiro Kikuchi; Yusuke Furukawa; Hiroaki Goto; Masayoshi Minegishi; Shotaro Iwamoto; Kanji Sugita
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

8.  NUCKS1 is a novel RAD51AP1 paralog important for homologous recombination and genome stability.

Authors:  Ann C Parplys; Weixing Zhao; Neelam Sharma; Torsten Groesser; Fengshan Liang; David G Maranon; Stanley G Leung; Kirsten Grundt; Eloïse Dray; Rupa Idate; Anne Carine Østvold; David Schild; Patrick Sung; Claudia Wiese
Journal:  Nucleic Acids Res       Date:  2015-08-31       Impact factor: 16.971

9.  Nucks1 synergizes with Trp53 to promote radiation lymphomagenesis in mice.

Authors:  Yangbo Yue; Stanley G Leung; Yueyong Liu; Yurong Huang; Kirsten Grundt; Anne-Carine Østvold; Kuang-Yu Jen; David Schild; Jian-Hua Mao; Claudia Wiese
Journal:  Oncotarget       Date:  2016-09-20

10.  Identification of Novel Serum MicroRNAs in Age-Related Macular Degeneration.

Authors:  Hanan ElShelmani; Michael A Wride; Tahira Saad; Sweta Rani; David J Kelly; David Keegan
Journal:  Transl Vis Sci Technol       Date:  2020-03-30       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.